
X
Gilead will test remdesivir in children with COVID-19
https://pharmaphorum.com/news/gilead-will-test-remdesivir-in-children-with-covid-19/
First disease modifying therapy approved in paediatric MS
Paediatric Clinical Trial
PARADIGM study meets primary endpoint.
Epidiolex could become a blockbuster if approved in all uses.
Company can move in after United Therapeutics withdrew its product Unituxin
FDA to provide guidance during development.